{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:44:54Z","timestamp":1788396294304,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subphenotypes were recently reported within clinical acute respiratory distress syndrome (ARDS), with distinct outcomes and therapeutic responses. Experimental models have long been used to mimic features of ARDS pathophysiology, but the presence of distinct subphenotypes among preclinical ARDS remains unknown. This review will investigate whether: 1) subphenotypes can be identified among preclinical ARDS models; 2) such subphenotypes can identify some responsive traits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will include comparative preclinical (in vivo and ex vivo) ARDS studies published between 2009 and 2019 in which pre-specified therapies were assessed (interleukin (IL)-10, IL-2, stem cells, beta-agonists, corticosteroids, fibroblast growth factors, modulators of the receptor for advanced glycation end-products pathway, anticoagulants, and halogenated agents) and outcomes compared to a control condition. The primary outcome will be a composite of the four key features of preclinical ARDS as per the American Thoracic Society consensus conference (histologic evidence of lung injury, altered alveolar-capillary barrier, lung inflammatory response, and physiological dysfunction). Secondary outcomes will include the single components of the primary composite outcome, net alveolar fluid clearance, and death. MEDLINE, Embase, and Cochrane databases will be searched electronically and data from eligible studies will be extracted, pooled, and analyzed using random-effects models. Individual study reporting will be assessed according to the Animal Research: Reporting of In Vivo Experiments guidelines. Meta-regressions will be performed to identify subphenotypes prior to comparing outcomes across subphenotypes and treatment effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will inform on the presence and underlying pathophysiological features of subphenotypes among preclinical models of ARDS and should help to determine whether sufficient evidence exists to perform preclinical trials of subphenotype-targeted therapies, prior to potential clinical translation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO (ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=157236\">CRD42019157236<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-020-01337-9","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:03:33Z","timestamp":1586257413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"name":"for the ESICM Translational Biology Group of the Acute Respiratory Failure section","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Carla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanifa","family":"Boukail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pinol-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"De Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiko","family":"Blondonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine B.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Calfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bastarache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Laffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole P.","family":"Juffermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe D.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R. M.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Jabaudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377:562\u201372.","journal-title":"N Engl J Med"},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788\u2013800.","journal-title":"JAMA."},{"key":"1337_CR3","first-page":"2526","volume":"307","author":"ARDS Definition Task Force","year":"2012","unstructured":"Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND. Caldwell E, et al. acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526\u201333.","journal-title":"JAMA"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1164\/rccm.201512-2544CP","volume":"194","author":"HC Prescott","year":"2016","unstructured":"Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu VX. Toward smarter lumping and smarter splitting: rethinking strategies for Sepsis and acute respiratory distress syndrome clinical trial design. Am J Respir Crit Care Med. 2016;194:147\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"1337_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.accpm.2017.08.006","volume":"37","author":"M Jabaudon","year":"2018","unstructured":"Jabaudon M, Blondonnet R, Audard J, Fournet M, Godet T, Sapin V, et al. Recent directions in personalised acute respiratory distress syndrome medicine. Anaesth Crit Care Pain Med. 2018;37:251\u20138.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MCC.0000000000000571","volume":"25","author":"P Sinha","year":"2019","unstructured":"Sinha P, Calfee CS. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine. Curr Opin Crit Care. 2019;25:12\u201320.","journal-title":"Curr Opin Crit Care"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-016-4331-6","volume":"42","author":"JR Beitler","year":"2016","unstructured":"Beitler JR, Goligher EC, Schmidt M, Spieth PM, Zanella A, Martin-Loeches I, et al. Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Med. 2016;42:756\u201367.","journal-title":"Intensive Care Med"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611\u201320.","journal-title":"Lancet Respir Med"},{"key":"1337_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","volume":"72","author":"LD Bos","year":"2017","unstructured":"Bos LD, Schouten LR, van Vught LA, Wiewel MA, Ong DSY, Cremer O, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72:876\u201383.","journal-title":"Thorax"},{"key":"1337_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","volume":"195","author":"KR Famous","year":"2017","unstructured":"Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1337_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","volume":"6","author":"CS Calfee","year":"2018","unstructured":"Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6:691\u20138.","journal-title":"Lancet Respir Med"},{"key":"1337_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.","journal-title":"Nat Rev Dis Primers"},{"key":"1337_CR14","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379\u201399.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725\u201338.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1337_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1164\/rccm.201612-2415CI","volume":"196","author":"JG Laffey","year":"2017","unstructured":"Laffey JG, Kavanagh BP. Fifty years of research in ARDS. Insight into acute respiratory distress syndrome. From models to patients. Am J Respir Crit Care Med. 2017;196:18\u201328.","journal-title":"Am J Respir Crit Care Med"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00134-016-4268-9","volume":"42","author":"PRM Rocco","year":"2016","unstructured":"Rocco PRM, Nieman GF. ARDS: what experimental models have taught us. Intensive Care Med. 2016;42:806\u201310.","journal-title":"Intensive Care Med"},{"issue":"9","key":"1337_CR18","doi-asserted-by":"publisher","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","volume":"306","author":"CDF McAuley","year":"2014","unstructured":"McAuley CDF, Hamid GF, Laffey UI, Abbott JG. McKenna J, et al. clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol. 2014;306(9):L809\u201315.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/thoraxjnl-2018-211576","volume":"74","author":"J Park","year":"2019","unstructured":"Park J, Kim S, Lim H, Liu A, Hu S, Lee J, et al. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E coli pneumonia. Thorax. 2019;74:43\u201350.","journal-title":"Thorax"},{"key":"1337_CR20","doi-asserted-by":"publisher","first-page":"16357","DOI":"10.1073\/pnas.0907996106","volume":"106","author":"JW Lee","year":"2009","unstructured":"Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009;106:16357\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1337_CR21","doi-asserted-by":"crossref","unstructured":"Ross JT, Nesseler N, Lee J-W, Ware LB, Matthay MA. The ex vivo human lung: research value for translational science. JCI Insight. 2019;4(11).","DOI":"10.1172\/jci.insight.128833"},{"key":"1337_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","volume":"7","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7:154\u201362.","journal-title":"Lancet Respir Med"},{"key":"1337_CR23","doi-asserted-by":"publisher","first-page":"S569","DOI":"10.1097\/CCM.0b013e3181f1ff1d","volume":"38","author":"MA Matthay","year":"2010","unstructured":"Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med. 2010;38:S569\u201373.","journal-title":"Crit Care Med"},{"key":"1337_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ajt.12564","volume":"14","author":"LB Ware","year":"2014","unstructured":"Ware LB, Landeck M, Koyama T, Zhao Z, Singer J, Kern R, et al. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors. Am J Transplant. 2014;14:621\u20138.","journal-title":"Am J Transplant"},{"key":"1337_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1164\/rccm.201012-2090OC","volume":"184","author":"MA Matthay","year":"2011","unstructured":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, et al. Randomized, placebo-controlled clinical trial of an aerosolized \u03b22-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184:561\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1337_CR26","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.1038\/s41598-017-07638-2","volume":"7","author":"R Blondonnet","year":"2017","unstructured":"Blondonnet R, Audard J, Belville C, Clairefond G, Lutz J, Bouvier D, et al. RAGE inhibition reduces acute lung injury in mice. Sci Rep. 2017;7:7208.","journal-title":"Sci Rep"},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-019-45798-5","volume":"9","author":"J Audard","year":"2019","unstructured":"Audard J, Godet T, Blondonnet R, Joffredo J-B, Paquette B, Belville C, et al. Inhibition of the receptor for advanced Glycation end-products in acute respiratory distress syndrome: a randomised laboratory trial in piglets. Sci Rep. 2019;9:9227.","journal-title":"Sci Rep"},{"issue":"20","key":"1337_CR28","doi-asserted-by":"publisher","first-page":"30048","DOI":"10.1016\/S2213-2600(20)30048-5","volume":"8","author":"K Reddy","year":"2020","unstructured":"Reddy K, O\u2019Kane C, McAuley D. Corticosteroids in acute respiratory distress syndrome: a step forward, but more evidence is needed. Lancet Respir Med. 2020;8(20):30048\u20135. https:\/\/doi.org\/10.1016\/S2213-2600(20)30048-5 [Epub ahead of print].","journal-title":"Lancet Respir Med"},{"key":"1337_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/atm.2018.01.08","volume":"6","author":"M Camprub\u00ed-Rimblas","year":"2018","unstructured":"Camprub\u00ed-Rimblas M, Tantiny\u00e0 N, Bringu\u00e9 J, Guillamat-Prats R, Artigas A. Anticoagulant therapy in acute respiratory distress syndrome. Ann Transl Med. 2018;6:36.","journal-title":"Ann Transl Med"},{"key":"1337_CR30","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","volume":"195","author":"M Jabaudon","year":"2017","unstructured":"Jabaudon M, Boucher P, Imhoff E, Chabanne R, Faure J-S, Roszyk L, et al. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195:792\u2013800.","journal-title":"Am J Respir Crit Care Med"},{"key":"1337_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1337_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1258\/la.2010.009117","volume":"44","author":"CR Hooijmans","year":"2010","unstructured":"Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab Anim. 2010;44:170\u20135.","journal-title":"Lab Anim"},{"key":"1337_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1258\/la.2011.011056","volume":"45","author":"RBM de Vries","year":"2011","unstructured":"de Vries RBM, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. A search filter for increasing the retrieval of animal studies in Embase. Lab Anim. 2011;45:268\u201370.","journal-title":"Lab Anim"},{"key":"1337_CR34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1\u201334.","journal-title":"J Clin Epidemiol"},{"key":"1337_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"1337_CR36","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ."},{"key":"1337_CR37","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ."},{"key":"1337_CR38","doi-asserted-by":"publisher","first-page":"e1001489","DOI":"10.1371\/journal.pmed.1001489","volume":"10","author":"VC Henderson","year":"2013","unstructured":"Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med. 2013;10:e1001489.","journal-title":"PLoS Med"},{"key":"1337_CR39","doi-asserted-by":"publisher","first-page":"e1001010","DOI":"10.1371\/journal.pmed.1001010","volume":"8","author":"J Kimmelman","year":"2011","unstructured":"Kimmelman J, London AJ. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med. 2011;8:e1001010.","journal-title":"PLoS Med"},{"key":"1337_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"1337_CR41","volume-title":"Mplus Version 8 User\u2019s Guide. Muthen & Muthen","author":"LK Muthen","year":"2017","unstructured":"Muthen LK, Muthen B. Mplus Version 8 User\u2019s Guide. Muthen & Muthen; 2017."},{"key":"1337_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139\u201345.","journal-title":"Contemp Clin Trials"},{"key":"1337_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2288-8-32","volume":"8","author":"JO Friedrich","year":"2008","unstructured":"Friedrich JO, Adhikari NKJ, Beyene J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008;8:32.","journal-title":"BMC Med Res Methodol"},{"key":"1337_CR44","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","volume":"19","author":"S Chinn","year":"2000","unstructured":"Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000;19:3127\u201331.","journal-title":"Stat Med"},{"key":"1337_CR45","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"1337_CR46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S2213-2600(17)30187-X","volume":"5","author":"NJ Meyer","year":"2017","unstructured":"Meyer NJ, Calfee CS. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir Med. 2017;5:512\u201323.","journal-title":"Lancet Respir Med"},{"key":"1337_CR47","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00134-018-5327-1","volume":"44","author":"M Jabaudon","year":"2018","unstructured":"Jabaudon M, Blondonnet R, Pereira B, Cartin-Ceba R, Lichtenstern C, Mauri T, et al. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data. Intensive Care Med. 2018;44:1388\u201399.","journal-title":"Intensive Care Med"},{"key":"1337_CR48","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","volume":"44","author":"P Sinha","year":"2018","unstructured":"Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS, et al. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018;44:1859\u201369.","journal-title":"Intensive Care Med"},{"key":"1337_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1164\/rccm.201809-1808OC","volume":"200","author":"LDJ Bos","year":"2019","unstructured":"Bos LDJ, Scicluna BP, Ong DSY, Cremer O, van der Poll T, Schultz MJ. Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles. Am J Respir Crit Care Med. 2019;200:42\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"1337_CR50","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1097\/CCM.0000000000004018","volume":"47","author":"GD Kitsios","year":"2019","unstructured":"Kitsios GD, Yang L, Manatakis DV, Nouraie M, Evankovich J, Bain W, et al. Host-response subphenotypes offer prognostic enrichment in patients with or at risk for acute respiratory distress syndrome. Crit Care Med. 2019;47:1724\u201334.","journal-title":"Crit Care Med"},{"key":"1337_CR51","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41598-019-39017-4","volume":"9","author":"A Viswan","year":"2019","unstructured":"Viswan A, Ghosh P, Gupta D, Azim A, Sinha N. Distinct metabolic Endotype mirroring acute respiratory distress syndrome (ARDS) subphenotype and its heterogeneous biology. Sci Rep. 2019;9:2108.","journal-title":"Sci Rep"},{"key":"1337_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ccc.2019.08.012","volume":"36","author":"A Sarma","year":"2020","unstructured":"Sarma A, Calfee CS, Ware LB. Biomarkers and precision medicine: state of the art. Crit Care Clin. 2020;36:155\u201365.","journal-title":"Crit Care Clin"},{"key":"1337_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13054-019-2655-7","volume":"23","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kerti SJ, Lewis AJ, Kennedy J, Brant E, Griepentrog JE, et al. Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids. Crit Care. 2019;23:384.","journal-title":"Crit Care"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01337-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-020-01337-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01337-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:28:47Z","timestamp":1617751727000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01337-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01337-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}